CN109706185B - Method for realizing gene knockout based on base editing system mutation initiation codon and application - Google Patents

Method for realizing gene knockout based on base editing system mutation initiation codon and application Download PDF

Info

Publication number
CN109706185B
CN109706185B CN201910105331.4A CN201910105331A CN109706185B CN 109706185 B CN109706185 B CN 109706185B CN 201910105331 A CN201910105331 A CN 201910105331A CN 109706185 B CN109706185 B CN 109706185B
Authority
CN
China
Prior art keywords
gene
target
initiation codon
sequence
abe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910105331.4A
Other languages
Chinese (zh)
Other versions
CN109706185A (en
Inventor
马旭
李广磊
金孝华
王鑫杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute Of Science And Technology National Health Commission
Original Assignee
Institute Of Science And Technology National Health Commission
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Science And Technology National Health Commission filed Critical Institute Of Science And Technology National Health Commission
Priority to CN201910105331.4A priority Critical patent/CN109706185B/en
Publication of CN109706185A publication Critical patent/CN109706185A/en
Application granted granted Critical
Publication of CN109706185B publication Critical patent/CN109706185B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for realizing gene knockout based on base editing system mutation initiation codon and application thereof. The gene knockout method is based on an accurate single base editing technology, and carries out mutation aiming at an encoding gene initiation codon ATG, so that the translation initiation function can not be normally exerted, and the goal of knocking out a target gene is achieved. The method specifically comprises the following steps: selecting a target sequence which is located in a translation initiation region of a gene to be knocked out and is 20bp-NGG or CCN-20bp, and enabling the target sequence to comprise a complete initiation codon ATG; and (3) positioning ABE or BE4 to a target sequence by using the sgRNA sequence, carrying out A-to-G, T-C or G-to-A mutation on a target single base in the ATG of the initiation codon of the target gene, and destroying the initiation codon so as to realize gene knockout. The knockout method is more efficient, more accurate and less in off-target effect, and realizes knockout of genes which cannot be knocked out by a part of conventional methods.

Description

Method for realizing gene knockout based on base editing system mutation initiation codon and application
Technical Field
The invention relates to a gene knockout strategy, in particular to a gene knockout method based on initiation codon base editing and application thereof.
Background
Gene knockout is the loss or inactivation of a gene of an organism by various molecular manipulations using molecular genetic techniques, and further, the inability to function normally.
In the conventional gene knock-out, it is mainly performed by a homologous recombination method. The method begins with the construction of a DNA vector containing the desired mutation, which contains at least 2kb of homology with the target sequence (Hall et al, 2009). Constructs can be delivered to stem cells by electrotransfection or microinjection. The DNA construct is then recombined into the cellular DNA in time by virtue of the cell's own repair. However, this is a inefficient process, since intracellular homologous recombination accounts for only 10 of DNA recombination-2To 10-3(Hall et al.,2009)。
Subsequently, editing techniques based on site-specific nucleases were developed. Currently, Zinc Finger Nucleases (ZFNs) (Santiago et al, 2008), Transcription activator-like effector nucleases (TALENs) (joint and Sander,2012), and aggregation regularly spaced short palindromic repeats (CRISPRs) (Gaj et al, 2013) are included. These three methods involve the precise targeting of DNA sequences to introduce double-stranded DNA breaks (DSBs) and then attempt to repair the double-stranded breaks using cellular repair mechanisms, usually by non-homologous end joining (NHEJ). This repair may result in insertion or deletion of base pairs, which in turn causes a frameshift mutation. Such mutations can disable the gene for knock-out purposes (Gaj et al, 2013) of a particular gene. In addition, CRISPR achieves knock-in (knock-in) by homologous recombination for repair in the presence of a template. Compared with homologous recombination, the process is more efficient, and then allele knockout can be realized more easily.
The CRISPR/Cas9 system is the technology with the fastest development and the widest application in the field of gene editing due to the characteristics of simplicity, high efficiency, low cost and the like, and the revolution of the field of gene editing is initiated. Currently, the CRISPR/Cas9 system has been successfully used for studies on DNA knock-out, knock-in, substitution, modification, labeling, RNA modification, and gene transcription regulation (Hsu et al, 2014; Komor et al, 2017 a). And has been successfully applied to gene editing in a number of species (Barrangou and Doudna, 2016; Komor et al, 2017 a). However, due to the low HDR efficiency (integration rarely occurs) and the easy generation of random insertions and deletions (indels) by the non-homologous end joining mechanism, new bases may be randomly introduced near the breakpoint, resulting in inaccurate gene editing. In addition, CRISPR/Cas 9-mediated gene editing has some off-target effects (Gorski et al, 2017).
Disclosure of Invention
One of the purposes of the invention is to provide a high-efficiency and accurate gene knockout strategy.
The base editing technology is a novel gene editing tool constructed based on CRISPR/Cas9 technology. There are currently Cytosine Base Editors (CBEs) and guanine base editors (ABEs). The cytosine base editor is the fusion of dCas9 or Cas9 nickase with rat cytidine deaminase APOBEC1, which converts cytosine (C) to uracil (U) by deamination, after which uracil (U) is converted to thymine (T) by DNA replication or repair. Similarly, it can also convert guanine (G) to adenine (A). It is capable of introducing point mutations in a target gene accurately and efficiently without the need for double-stranded DNA breaks or any donor template, exhibiting great gene editing potential (Komor et al, 2016). The cytosine base editor does not need to cut DNA to cause DSB, the formed indel is lower than 1 percent, and the realized gene editing is more accurate (Komor et al, 2016); moreover, this approach reduces off-target efficiency to 10-fold below natural background, achieving safer gene editing (Nishida et al, 2016). The most commonly used at present is BE3(Komor et al, 2016), more efficient BE4(Komor et al, 2017 b).
The adenine base editor induces nucleotide changes at a wide range of target genomic loci in human cells (gaudell et al, 2017). In the ABE system, TadA: the TadA heterodimer is directed to the target site by the Cas9 n/single guide rna (sgrna) complex, and the engineered TadA converts adenine (a) to inosine (I) in single stranded genomic DNA as an active tRNA adenosine deaminase, subsequently leading to a guanine (G) mutation in the genome during DNA repair or DNA replication (gaudell et al, 2017). Similarly, it can also convert thymine (T) to cytosine (C). To this end, the BE and ABE systems, which can programmably introduce all four transitions (C to T, G to A, A to G and T to C) on a target gene of a genome, greatly expand the base editing function.
Based on the accurate and specific single base editing mediated by the CBEs or ABEs system, the inventor skillfully designs a gene knockout strategy: mutating the ATG of the target gene initiation codon into ATA by G-to-A mutation by utilizing a BE4 system; or ATG to ACG by T to C mutation or ATG to GTG by A to G mutation using the ABE system. The translation initiation of the gene is prevented by mutating the initiation codon, thereby realizing the purpose of gene silencing and knockout.
According to a first aspect of the present invention, there is provided a gene knockout method comprising:
determining an initiation codon of a gene to be knocked out, and searching and designing a 20bp-NGG target sequence (PAM sequence) to enable the PAM sequence to comprise a complete initiation codon ATG; and positioning the ABE to a target sequence by utilizing the sgRNA sequence to change a target single base A in the initiation codon into G, so that the initiation codon ATG is mutated into GTG to realize the gene knockout purpose.
Alternatively, determining the initiation codon of the gene to be knocked out, and searching and designing a CCN-20bp target sequence (PAM sequence) to enable the target sequence to contain a complete initiation codon ATG; and positioning ABE and BE4 to a target sequence by using the sgRNA sequence to change a target single base T in an initiation codon into C or G into A, so that the initiation codon ATG is mutated into ACG or ATA to realize the gene knockout purpose.
The target single base A or T is preferably located at positions 4-7 of the target sequence if ABE is used, and the target single base G is preferably located at positions 4-8 of the target sequence if BE4 is used;
the sgRNA sequence is a 20bp sequence which is complementary and corresponds to a target sequence.
According to the invention, ABE can be selected from pCMV-ABEmax SEQ ID NO.1
BE4 is selected from: pCMV-AncBE4max SEQ ID NO. 2; pCMV-BE4max SEQ ID NO.3
The method according to the invention can be used to knock out the following eleven target genes: human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1, and mouse TIM3 and LAG3, the sgRNA sequences corresponding thereto are complementary to the target gene sequences shown in sequences one to ten, respectively.
According to a second aspect of the invention, there is provided the use of the above method for knock-out of a human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 gene in the cell line HEK 293T.
According to a third aspect of the invention, there is provided the use of the above method for knock-out of a human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 gene in a human T cell.
According to a fourth aspect of the present invention there is provided an isolated T cell or cell line or subculture thereof obtained according to the above use.
According to a fifth aspect of the present invention, there is provided a kit for gene knockout, comprising the sgRNA, ABE, BE3, BE4 described above (corresponding to a gene to BE knocked out) and a corresponding amplification reagent.
The invention utilizes the base editing technology developed on the basis of CRISPR/Cas9, and changes and destroys the ATG of the initiation codon through the accurate single base mutation from A to G, T to C or from G to A, thereby establishing a gene knockout strategy which is more efficient, more accurate and less in off-target effect than CRISPR/Cas 9.
Reference to the literature
Barrangou,R.,Doudna,J.A.,2016.Applications of CRISPR technologies in research and beyond.Nature Biotechnology 34,933.
Gaj,T.,Gersbach,C.A.,Barbas,C.F.,2013.ZFN,TALEN,and CRISPR/Cas-based methods for genome engineering.Trends in Biotechnology 31,397-405.
Gaudelli,N.M.,Komor,A.C.,Rees,H.A.,Packer,M.S.,Badran,A.H.,Bryson,D.I.,Liu,D.R.,2017.Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage.Nature551,464.
Gorski,S.A.,Vogel,J.,Doudna,J.A.,2017.RNA-based recognition and targeting:sowing the seeds of specificity.Nature Reviews Molecular Cell Biology 18,215.
Hall,B.,Limaye,A.,Kulkarni,A.B.,2009.Overview:generation of gene knockout mice.Curr Protoc Cell Biol Chapter 19,Unit 19 12 19 12 11-17.
Hsu,Patrick D.,Lander,Eric S.,Zhang,F.,2014.Development and Applications of CRISPR-Cas9for Genome Engineering.Cell 157,1262-1278.
Joung,J.K.,Sander,J.D.,2012.TALENs:a widely applicable technology for targeted genome editing.Nature Reviews Molecular Cell Biology 14,49.
Komor,A.C.,Badran,A.H.,Liu,D.R.,2017a.CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.Cell 168,20-36.
Komor,A.C.,Kim,Y.B.,Packer,M.S.,Zuris,J.A.,Liu,D.R.,2016.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature 533,420.
Komor,A.C.,Zhao,K.T.,Packer,M.S.,Gaudelli,N.M.,Waterbury,A.L.,Koblan,L.W.,Kim,Y.B.,Badran,A.H.,Liu,D.R.,2017b.Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity.Sci Adv 3,eaao4774.
Nishida,K.,Arazoe,T.,Yachie,N.,Banno,S.,Kakimoto,M.,Tabata,M.,Mochizuki,M.,Miyabe,A.,Araki,M.,Hara,K.Y.,Shimatani,Z.,Kondo,A.,2016.Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.Science 353.
Ren,B.,Yan,F.,Kuang,Y.,Li,N.,Zhang,D.,Zhou,X.,Lin,H.,Zhou,H.,2018.Improved Base Editor for Efficiently Inducing Genetic Variations in Rice with CRISPR/Cas9-Guided Hyperactive hAID Mutant.Molecular Plant 11,623-626.
Santiago,Y.,Chan,E.,Liu,P.-Q.,Orlando,S.,Zhang,L.,Urnov,F.D.,Holmes,M.C.,Guschin,D.,Waite,A.,Miller,J.C.,Rebar,E.J.,Gregory,P.D.,Klug,A.,Collingwood,T.N.,2008.
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.Proceedings of the National Academy of Sciences 105,5809-5814.
Drawings
FIG. 1 is a schematic diagram of the realization of targeted gene knockout using ATG mutation according to the present invention;
FIG. 2 is a schematic structural diagram of pCMV-AncBE4max used in the present invention;
FIG. 3 is a schematic structural view of pCMV-BE4max used in the present invention;
FIG. 4 is a schematic diagram of the structure of pCMV-ABEmax used in the present invention;
FIG. 5 shows an example of flow cytometry detection of GFP positivity by transfecting sgRNA and ABE or BE4 plasmids of the present invention;
FIG. 6 is a diagram showing the gene editing efficiency and editing site analysis of the present invention, taking HDAC1 gene as an example;
FIG. 7 is a diagram showing the gene editing efficiency and editing site analysis in the present invention, taking the SOX9 gene as an example;
FIG. 8 shows the editing efficiency and editing site analysis of monoclonal cells obtained by sorting the ATG (initiation codon of the target gene) according to the present invention, taking the HDAC1 gene as an example;
FIG. 9 shows the editing efficiency and editing site analysis of the monoclonal cell obtained by sorting the ATG editing start codon of the target gene according to the present invention, taking the SOX9 gene as an example;
FIG. 10 shows Western blot analysis of target genes of monoclonal cells edited by ATG, the initiation codon of the target gene obtained by sorting, using HDAC1 gene as an example.
Detailed Description
The embodiments of the present invention will now be described in detail and fully with reference to the accompanying examples, which are provided for illustration of the embodiments of the present invention and are not to be construed as limiting the scope of the invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used are not indicated to the manufacturer, and are considered to be conventional products available through commercial purchase.
The above description is only exemplary of the invention and should not be taken as limiting the invention, as any modification, equivalent replacement, or improvement made within the spirit and principle of the invention should be included in the protection scope of the invention.
Base site directed editing is the use of sgrnas to target ABE or BE4 to or to specific target sites, and the selection and design of the target gene specific sgrnas is the key to the present invention. The sgRNA is selected and designed as follows:
a20 bp-NGG or CCN-20bp target sequence (PAM sequence) containing the initiation codon ATG of the gene is selected, and the target single base A or T is preferably located at the 4 th to 7 th positions of the target sequence by ABE, and the target single base G is preferably located at the 4 th to 8 th positions of the target sequence by BE4 (FIG. 1-FIG. 4).
A 20bp sgRNA sequence complementary to the target sequence was prepared.
For eleven target genes, human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and mouse TIM3 and LAG3, the following target gene sequences were selected to design the corresponding sgRNAs (PAM in bold; candidate mutation codes in italic underlined):
hAPOE
ABE T to C
Sg-1:
Figure BDA0001966595840000051
SEQ ID NO.4
ABE A to G
Sg-2:
Figure BDA0001966595840000052
SEQ ID NO.5
hPD1
ABE A to G
Sg-1:
Figure BDA0001966595840000053
SEQ ID NO.6
hLAG3
BE4 G to A
Sg-1:
Figure BDA0001966595840000061
SEQ ID NO.7
ABE T to C
Sg-2:
Figure BDA0001966595840000062
SEQ ID NO.8
hTIGIIT
ABE T to C
Sg-1:
Figure BDA0001966595840000063
SEQ ID NO.9
BE4 G to A
Sg-2:
Figure BDA0001966595840000064
SEQ ID NO.10
hVISTA
ABE A to G
Sg-1:
Figure BDA0001966595840000065
SEQ ID NO.11
hCD224
ABE A to G
Sg-1:
Figure BDA0001966595840000066
SEQ ID NO.12
Seven, hCD160
ABE A to G
Sg-1:
Figure BDA0001966595840000067
SEQ ID NO.13
Eight hSOX9
BE4 G to A
Sg-1:
Figure BDA0001966595840000068
SEQ ID NO.14
Nine mTIM3
BE4 G to A
Sg-1:
Figure BDA0001966595840000069
SEQ ID NO.15
ABE T to C
Sg-2:
Figure BDA00019665958400000610
SEQ ID NO.16
Ten mLAG3
BE4G to A
Sg-1:
Figure BDA0001966595840000071
SEQ ID NO.17
ABE T to C
Sg-2:
Figure BDA0001966595840000072
SEQ ID NO.18
Eleven HDAC1
ABE A to G
Sg-1:
Figure BDA0001966595840000073
SEQ ID NO.19
Aiming at the selected target gene sequences, human APOE (item 2), PD1, LAG3 (item 2), TIGIT (item 2), VISTA, CD224, CD160, SOX9, HDAC1, mouse TIM3 (item 2) and LAG3 (item 2), corresponding sgRNA expression vectors are constructed, and different sgRNAs are respectively introduced into pGL3-U6-sgRNA vectors and SEQ ID NO. 20.
Example 1
ABE or BE4 mediated base editing is carried out on the cell strain, and the initiation codon is mutated to realize gene knockout.
The invention carries out the culture and transfection of eukaryotic cells and carries out the gene knockout of cell strains (through electrotransformation or lipofection). The following examples are the methods of lipofection of HEK293T cells into human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and other genes.
(1) HEK293T cells were seeded in DMEM medium containing 10% FBS (HyClone, SH30022.01B) containing penicillin (100U/ml) and streptomycin (100. mu.g/ml).
(2) Cells were plated in 6-well plates the day before transfection. The next day, transfection was performed when the density reached 70% -80%.
(3) According to LipofectamineTM2000Transfection Reagent (Invitrogen,11668-019), 2. mu.g of ABE or BE4 plasmid was mixed with 2. mu.g of the corresponding pGL3-U6-sgRNA plasmid, co-transfected into cells, the solution was changed after 6 to 8 hours, the cells were harvested after 72 hours, and the Transfection efficiency of the cells was determined by a flow analyzer (FIG. 5).
(4) Genotyping analysis
A. A portion of the cells was lysed in a lysis buffer (10. mu.M Tris-HCl,0.4M NaCl, 2. mu.M EDTA, 1% SDS) with 100. mu.g/ml proteinase K, extracted with phenol-chloroform and solubilized to 50. mu.l ddH2And (4) in O.
B. PCR amplification is carried out by using a pair of primers N-For and N-Rev, PCR recovery products are obtained by AxyPrep PCR clean purification, 200ng is uniformly diluted to 20 mu l For denaturation and annealing, and the procedures are as follows: 95 ℃ for 5 min; 95-85 ℃ at-2 ℃/s; at-0.1 ℃/s at 85-25 ℃; hold at 4 ℃.
C. The PCR product was recovered and subjected to A-addition reaction using rTaq. The reaction system of adding A is as follows:
700-800ng PCR recovery product
5μl 10X Buffer(Mg2+PLUS)
4μl dNTP
0.5μl rTaq(TAKARA,R001AM)
Water was added to the reaction system to 50. mu.l.
After incubation at 37 ℃ for 30 min, 1. mu.l of the product was ligated with pMD19-T vector (TAKARA,3271) and DH5 competent cells (TransGen, CD201) were transformed.
D. The single clone is picked, the universal primer M13-F is used for sequencing each target gene mutation, and the sequencing result is as follows (the bold represents PAM; the italic represents the mutant code, and the italic underline represents the mutant base):
1.hAPOE
Sg-1:
Figure BDA0001966595840000081
Mut:
Figure BDA0001966595840000082
Sg-2:
Figure BDA0001966595840000083
Mut:
Figure BDA0001966595840000084
2.hPD1
Sg-1:
Figure BDA0001966595840000085
Mut:
Figure BDA0001966595840000086
3.hLAG3
Sg-1:
Figure BDA0001966595840000087
Mut:
Figure BDA0001966595840000088
Sg-2:
Figure BDA0001966595840000089
Mut:
Figure BDA00019665958400000810
4.hTIGIT
Sg-1:
Figure BDA00019665958400000811
Mut:
Figure BDA00019665958400000812
Sg-2:
Figure BDA00019665958400000813
Mut:
Figure BDA00019665958400000814
5.hVISTA
Sg-1:
Figure BDA0001966595840000091
Mut:
Figure BDA0001966595840000092
6.hCD224
Sg-1:
Figure BDA0001966595840000093
Mut:
Figure BDA0001966595840000094
hCD160 (FIGS. 6 and 8)
Sg-1:
Figure BDA0001966595840000095
Mut:
Figure BDA0001966595840000096
8.hSOX9
Sg-1:
Figure BDA0001966595840000097
Mut:
Figure BDA0001966595840000098
HDAC1 (FIG. 7, FIG. 9)
Sg-1:
Figure BDA0001966595840000099
Mut:
Figure BDA00019665958400000910
(5) Western blot detection knockout effect
Furthermore, when we performed western blot detection on the selected monoclonal cells of HDAC1, the protein of HDAC1 was not detected (fig. 10), and it is shown from the protein level that ATG mutation can successfully achieve target gene knockout.
The results show that: the initiation codon of the target gene is subjected to sgRNA targeted base mutation, so that the target gene cannot play a translation initiation role, and the successful knockout of human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9 and HDAC1 genes is realized.
Example 2
ABE or BE4 mediated base editing is carried out on primary cells, and the initiation codon is mutated to realize gene knockout.
As a general rule, human T cells are knocked out into primary cells (by electrotransfection or lipofection), as exemplified by electrotransfection.
(1) Separation and purification of PBMC cells:
A. collecting peripheral blood by using an anticoagulation tube, and shaking the collected peripheral blood and the anticoagulant while collecting;
B. mixing peripheral blood cells and lymphocyte separation liquid in equal volume, centrifuging, and sucking centrifuged leucocyte layer cells;
C. and mixing the obtained leucocyte layer cells with a serum-free cell culture medium 1640, centrifuging, and collecting precipitated cells, namely the PBMC cells.
The above separation process was repeated three times.
(2) Enrichment of CD 3-positive cells
A. Adjusting PBMC cell concentration to 50X106cell/ml。
B. 50. mu.l of CD3+ engineered antibodies cocktail was added to 1ml of the solution, mixed well and allowed to stand at room temperature for 5 minutes.
C. Adding 150 mul of magnet into each 1ml of the mixture, uniformly mixing the mixture, standing the mixture for 10 minutes at room temperature,
D. the centrifuge tube was placed on a magnetic rack and allowed to stand for 5 minutes, and the upper cell suspension was aspirated into a new 15ml centrifuge tube.
E. This operation was repeated once.
F. Cells were collected by centrifugation at 300g for 10 min at room temperature.
G. And (6) counting the cells.
(3) Electrotransfer of CD3 positive cells
A. Dispose the electrical swivel system
Add 8. mu.g BE3, BE4 or ABE plasmid and 8. mu.g corresponding pGL3-U6-sgRNA plasmid into 1.5ml centrifuge tube, and add 82. mu.l electrotransfer buffer and 18. mu.l supplement1 according to the instruction of Lonza Amaxa electrotransfer kit, mix well.
B. Harvesting 20X106The cells were placed in a 15ml centrifuge tube, centrifuged at 300g for 10 minutes and the supernatant discarded.
C. The cells were resuspended in the plasmid electrotransfer buffer mixture prepared in A and transferred to an electrotransfer cuvette.
D. The instrument was used for electrotransformation with the Lonza 2B, U-014 program.
E. The cells after electroporation were rapidly transferred to a pre-warmed AIM-V medium supplemented with 10% FBS and cultured in a 37 ℃ 5% carbon dioxide incubator for 2 hours.
F. Cell total fluid after electrotransformation, 1X106Cells were resuspended at density of one/ml and cultured overnight.
(4) Activated culture of T cells
A. After 24 hours of electroporation, 100U/ml IL-2 was added to the medium and CD3/CD28dynabeads were added at a ratio of 1:1 to activate T cells.
B. Half-changing the cell liquid every two days, or supplementing IL-2, and keeping the cell density at 1X106One per ml.
C. After 5 days of activation, the T cells were collected in 15ml centrifuge tubes, placed in a magnetic rack, and the supernatant was slowly transferred to another clean 15ml centrifuge tube and the procedure repeated once.
D. Centrifuge 300g at room temperature for 10 min, discard the supernatant, resuspend the cells in 10% FBS,300U/ml IL-2AIM-V medium, density controlled at 1X106One per ml.
E. Half-changing the cells every two days, or supplementing IL-2, and counting, the cells are maintained at 1X106One per ml.
(5) Genotyping analysis
A. The collected cells were lysed in a lysis solution (10. mu.M Tris-HCl,0.4M NaCl, 2. mu.M EDTA, 1% SDS) with 100. mu.g/ml proteinase K, extracted with phenol-chloroform, and then dissolved in 50. mu.l of deionized water.
B. PCR amplification is carried out by using a pair of primers N-For and N-Rev, PCR recovery products are obtained by AxyPrep PCR clean purification, 200ng is uniformly diluted to 20 mu l For denaturation and annealing, and the procedures are as follows: 95 ℃ for 5 min; 95-85 ℃ at-2 ℃/s; at-0.1 ℃/s at 85-25 ℃; hold at 4 ℃.
C. The PCR product was recovered and subjected to A-addition reaction using rTaq. The reaction system of adding A is as follows:
700-800ng PCR recovery product
5μl 10X Buffer(Mg2+PLUS)
4μl dNTP
0.5μl rTaq(TAKARA,R001AM)
Water was added to the reaction system to 50. mu.l.
After incubation at 37 ℃ for 30 min, 1. mu.l of the product was ligated with pMD19-T vector (TAKARA,3271) and DH5 competent cells (TransGen, CD201) were transformed.
D. The single clone is picked, and the mutation of each target gene of the T cell is sequenced by using a universal primer M13-F, and the sequencing result is as follows (the bold represents PAM; the italic represents a candidate mutation code son; the italic represents a mutation base):
1.hAPOE
Sg-1:
Figure BDA0001966595840000111
Mut:
Figure BDA0001966595840000112
Sg-2:
Figure BDA0001966595840000113
Mut:
Figure BDA0001966595840000114
2.hPD1
Sg-1:
Figure BDA0001966595840000115
Mut:
Figure BDA0001966595840000116
3.hLAG3
Sg-1:
Figure BDA0001966595840000117
Mut:
Figure BDA0001966595840000118
Sg-2:
Figure BDA0001966595840000119
Mut:
Figure BDA00019665958400001110
4.hTIGIT
Sg-1:
Figure BDA00019665958400001111
Mut:
Figure BDA00019665958400001112
Sg-2:
Figure BDA0001966595840000121
Mut:
Figure BDA0001966595840000122
5.hVISTA
Sg-1:
Figure BDA0001966595840000123
Mut:
Figure BDA0001966595840000124
6.hCD224
Sg-1:
Figure BDA0001966595840000125
Mut:
Figure BDA0001966595840000126
7.hCD160
Sg-1:
Figure BDA0001966595840000127
Mut:
Figure BDA0001966595840000128
8.hSOX9
Sg-1:
Figure BDA0001966595840000129
Mut:
Figure BDA00019665958400001210
9.HDAC1
Sg-1:
Figure BDA00019665958400001211
Mut:
Figure BDA00019665958400001212
the results show that: the target gene has sgRNA targeted base mutation, and the gene initiation codon ATG introduces mutation, so as to realize successful gene knockout on human APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and the like.
Example 3
Construction of ABE or BE 4-mediated knockout mice
The embryo collection, microinjection, embryo culture, embryo transplantation and the like of the mice are carried out according to the conventional operation. For example, TIM3 and LAG3 genes were used to construct knockout mice.
(1) Microinjection: fertilized eggs were injected with mRNA of ABE or BE4 and TIM 3-specific sgRNA (corresponding to the sequence nine above), or mRNA of ABE or BE4 and LAG 3-specific sgRNA (corresponding to the sequence ten above), respectively. Performing embryo transplantation conventionally;
(2) genotype analysis: extracting genome DNA from the tail of a conventional mouse, amplifying coding regions respectively by PCR, and performing Sanger sequencing, wherein the sequencing result is as follows (the bold represents PAM; the italic represents a mutant coder; and the italic represents a mutant base):
10.mTIM3
Sg-1:
Figure BDA0001966595840000131
Mut:
Figure BDA0001966595840000132
Sg-2:
Figure BDA0001966595840000133
Mut:
Figure BDA0001966595840000134
11.mLAG3
Sg-1:
Figure BDA0001966595840000135
Mut:
Figure BDA0001966595840000136
Sg-2:
Figure BDA0001966595840000137
Mut:
Figure BDA0001966595840000138
the above results confirm that mutations were introduced at the start codons of TIM3 and LAG3, and that construction of TIM3 and LAG3 knockout mice was successful.
Sequence listing
<110> institute of science and technology of the national institute of health and science and technology
<120> method for realizing gene knockout based on base editing system mutation initiation codon and application
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 8811
<212> DNA
<213> Artificial sequence ()
<400> 1
atatgccaag tacgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg 60
cccagtacat gaccttatgg gactttccta cttggcagta catctacgta ttagtcatcg 120
ctattaccat ggtgatgcgg ttttggcagt acatcaatgg gcgtggatag cggtttgact 180
cacggggatt tccaagtctc caccccattg acgtcaatgg gagtttgttt tggcaccaaa 240
atcaacggga ctttccaaaa tgtcgtaaca actccgcccc attgacgcaa atgggcggta 300
ggcgtgtacg gtgggaggtc tatataagca gagctggttt agtgaaccgt cagatccgct 360
agagatccgc ggccgctaat acgactcact atagggagag ccgccaccat gaaacggaca 420
gccgacggaa gcgagttcga gtcaccaaag aagaagcgga aagtctctga agtcgagttt 480
agccacgagt attggatgag gcacgcactg accctggcaa agcgagcatg ggatgaaaga 540
gaagtccccg tgggcgccgt gctggtgcac aacaatagag tgatcggaga gggatggaac 600
aggccaatcg gccgccacga ccctaccgca cacgcagaga tcatggcact gaggcaggga 660
ggcctggtca tgcagaatta ccgcctgatc gatgccaccc tgtatgtgac actggagcca 720
tgcgtgatgt gcgcaggagc aatgatccac agcaggatcg gaagagtggt gttcggagca 780
cgggacgcca agaccggcgc agcaggctcc ctgatggatg tgctgcacca ccccggcatg 840
aaccaccggg tggagatcac agagggaatc ctggcagacg agtgcgccgc cctgctgagc 900
gatttcttta gaatgcggag acaggagatc aaggcccaga agaaggcaca gagctccacc 960
gactctggag gatctagcgg aggatcctct ggaagcgaga caccaggcac aagcgagtcc 1020
gccacaccag agagctccgg cggctcctcc ggaggatcct ctgaggtgga gttttcccac 1080
gagtactgga tgagacatgc cctgaccctg gccaagaggg cacgcgatga gagggaggtg 1140
cctgtgggag ccgtgctggt gctgaacaat agagtgatcg gcgagggctg gaacagagcc 1200
atcggcctgc acgacccaac agcccatgcc gaaattatgg ccctgagaca gggcggcctg 1260
gtcatgcaga actacagact gattgacgcc accctgtacg tgacattcga gccttgcgtg 1320
atgtgcgccg gcgccatgat ccactctagg atcggccgcg tggtgtttgg cgtgaggaac 1380
gcaaaaaccg gcgccgcagg ctccctgatg gacgtgctgc actaccccgg catgaatcac 1440
cgcgtcgaaa ttaccgaggg aatcctggca gatgaatgtg ccgccctgct gtgctatttc 1500
tttcggatgc ctagacaggt gttcaatgct cagaagaagg cccagagctc caccgactcc 1560
ggaggatcta gcggaggctc ctctggctct gagacacctg gcacaagcga gagcgcaaca 1620
cctgaaagca gcgggggcag cagcgggggg tcagacaaga agtacagcat cggcctggcc 1680
atcggcacca actctgtggg ctgggccgtg atcaccgacg agtacaaggt gcccagcaag 1740
aaattcaagg tgctgggcaa caccgaccgg cacagcatca agaagaacct gatcggagcc 1800
ctgctgttcg acagcggcga aacagccgag gccacccggc tgaagagaac cgccagaaga 1860
agatacacca gacggaagaa ccggatctgc tatctgcaag agatcttcag caacgagatg 1920
gccaaggtgg acgacagctt cttccacaga ctggaagagt ccttcctggt ggaagaggat 1980
aagaagcacg agcggcaccc catcttcggc aacatcgtgg acgaggtggc ctaccacgag 2040
aagtacccca ccatctacca cctgagaaag aaactggtgg acagcaccga caaggccgac 2100
ctgcggctga tctatctggc cctggcccac atgatcaagt tccggggcca cttcctgatc 2160
gagggcgacc tgaaccccga caacagcgac gtggacaagc tgttcatcca gctggtgcag 2220
acctacaacc agctgttcga ggaaaacccc atcaacgcca gcggcgtgga cgccaaggcc 2280
atcctgtctg ccagactgag caagagcaga cggctggaaa atctgatcgc ccagctgccc 2340
ggcgagaaga agaatggcct gttcggaaac ctgattgccc tgagcctggg cctgaccccc 2400
aacttcaaga gcaacttcga cctggccgag gatgccaaac tgcagctgag caaggacacc 2460
tacgacgacg acctggacaa cctgctggcc cagatcggcg accagtacgc cgacctgttt 2520
ctggccgcca agaacctgtc cgacgccatc ctgctgagcg acatcctgag agtgaacacc 2580
gagatcacca aggcccccct gagcgcctct atgatcaaga gatacgacga gcaccaccag 2640
gacctgaccc tgctgaaagc tctcgtgcgg cagcagctgc ctgagaagta caaagagatt 2700
ttcttcgacc agagcaagaa cggctacgcc ggctacattg acggcggagc cagccaggaa 2760
gagttctaca agttcatcaa gcccatcctg gaaaagatgg acggcaccga ggaactgctc 2820
gtgaagctga acagagagga cctgctgcgg aagcagcgga ccttcgacaa cggcagcatc 2880
ccccaccaga tccacctggg agagctgcac gccattctgc ggcggcagga agatttttac 2940
ccattcctga aggacaaccg ggaaaagatc gagaagatcc tgaccttccg catcccctac 3000
tacgtgggcc ctctggccag gggaaacagc agattcgcct ggatgaccag aaagagcgag 3060
gaaaccatca ccccctggaa cttcgaggaa gtggtggaca agggcgcttc cgcccagagc 3120
ttcatcgagc ggatgaccaa cttcgataag aacctgccca acgagaaggt gctgcccaag 3180
cacagcctgc tgtacgagta cttcaccgtg tataacgagc tgaccaaagt gaaatacgtg 3240
accgagggaa tgagaaagcc cgccttcctg agcggcgagc agaaaaaggc catcgtggac 3300
ctgctgttca agaccaaccg gaaagtgacc gtgaagcagc tgaaagagga ctacttcaag 3360
aaaatcgagt gcttcgactc cgtggaaatc tccggcgtgg aagatcggtt caacgcctcc 3420
ctgggcacat accacgatct gctgaaaatt atcaaggaca aggacttcct ggacaatgag 3480
gaaaacgagg acattctgga agatatcgtg ctgaccctga cactgtttga ggacagagag 3540
atgatcgagg aacggctgaa aacctatgcc cacctgttcg acgacaaagt gatgaagcag 3600
ctgaagcggc ggagatacac cggctggggc aggctgagcc ggaagctgat caacggcatc 3660
cgggacaagc agtccggcaa gacaatcctg gatttcctga agtccgacgg cttcgccaac 3720
agaaacttca tgcagctgat ccacgacgac agcctgacct ttaaagagga catccagaaa 3780
gcccaggtgt ccggccaggg cgatagcctg cacgagcaca ttgccaatct ggccggcagc 3840
cccgccatta agaagggcat cctgcagaca gtgaaggtgg tggacgagct cgtgaaagtg 3900
atgggccggc acaagcccga gaacatcgtg atcgaaatgg ccagagagaa ccagaccacc 3960
cagaagggac agaagaacag ccgcgagaga atgaagcgga tcgaagaggg catcaaagag 4020
ctgggcagcc agatcctgaa agaacacccc gtggaaaaca cccagctgca gaacgagaag 4080
ctgtacctgt actacctgca gaatgggcgg gatatgtacg tggaccagga actggacatc 4140
aaccggctgt ccgactacga tgtggaccat atcgtgcctc agagctttct gaaggacgac 4200
tccatcgaca acaaggtgct gaccagaagc gacaagaacc ggggcaagag cgacaacgtg 4260
ccctccgaag aggtcgtgaa gaagatgaag aactactggc ggcagctgct gaacgccaag 4320
ctgattaccc agagaaagtt cgacaatctg accaaggccg agagaggcgg cctgagcgaa 4380
ctggataagg ccggcttcat caagagacag ctggtggaaa cccggcagat cacaaagcac 4440
gtggcacaga tcctggactc ccggatgaac actaagtacg acgagaatga caagctgatc 4500
cgggaagtga aagtgatcac cctgaagtcc aagctggtgt ccgatttccg gaaggatttc 4560
cagttttaca aagtgcgcga gatcaacaac taccaccacg cccacgacgc ctacctgaac 4620
gccgtcgtgg gaaccgccct gatcaaaaag taccctaagc tggaaagcga gttcgtgtac 4680
ggcgactaca aggtgtacga cgtgcggaag atgatcgcca agagcgagca ggaaatcggc 4740
aaggctaccg ccaagtactt cttctacagc aacatcatga actttttcaa gaccgagatt 4800
accctggcca acggcgagat ccggaagcgg cctctgatcg agacaaacgg cgaaaccggg 4860
gagatcgtgt gggataaggg ccgggatttt gccaccgtgc ggaaagtgct gagcatgccc 4920
caagtgaata tcgtgaaaaa gaccgaggtg cagacaggcg gcttcagcaa agagtctatc 4980
ctgcccaaga ggaacagcga taagctgatc gccagaaaga aggactggga ccctaagaag 5040
tacggcggct tcgacagccc caccgtggcc tattctgtgc tggtggtggc caaagtggaa 5100
aagggcaagt ccaagaaact gaagagtgtg aaagagctgc tggggatcac catcatggaa 5160
agaagcagct tcgagaagaa tcccatcgac tttctggaag ccaagggcta caaagaagtg 5220
aaaaaggacc tgatcatcaa gctgcctaag tactccctgt tcgagctgga aaacggccgg 5280
aagagaatgc tggcctctgc cggcgaactg cagaagggaa acgaactggc cctgccctcc 5340
aaatatgtga acttcctgta cctggccagc cactatgaga agctgaaggg ctcccccgag 5400
gataatgagc agaaacagct gtttgtggaa cagcacaagc actacctgga cgagatcatc 5460
gagcagatca gcgagttctc caagagagtg atcctggccg acgctaatct ggacaaagtg 5520
ctgtccgcct acaacaagca ccgggataag cccatcagag agcaggccga gaatatcatc 5580
cacctgttta ccctgaccaa tctgggagcc cctgccgcct tcaagtactt tgacaccacc 5640
atcgaccgga agaggtacac cagcaccaaa gaggtgctgg acgccaccct gatccaccag 5700
agcatcaccg gcctgtacga gacacggatc gacctgtctc agctgggagg tgactctggc 5760
ggctcaaaaa gaaccgccga cggcagcgaa ttcgagccca agaagaagag gaaagtctaa 5820
ccggtcatca tcaccatcac cattgagttt aaacccgctg atcagcctcg actgtgcctt 5880
ctagttgcca gccatctgtt gtttgcccct cccccgtgcc ttccttgacc ctggaaggtg 5940
ccactcccac tgtcctttcc taataaaatg aggaaattgc atcgcattgt ctgagtaggt 6000
gtcattctat tctggggggt ggggtggggc aggacagcaa gggggaggat tgggaagaca 6060
atagcaggca tgctggggat gcggtgggct ctatggcttc tgaggcggaa agaaccagct 6120
ggggctcgat accgtcgacc tctagctaga gcttggcgta atcatggtca tagctgtttc 6180
ctgtgtgaaa ttgttatccg ctcacaattc cacacaacat acgagccgga agcataaagt 6240
gtaaagccta gggtgcctaa tgagtgagct aactcacatt aattgcgttg cgctcactgc 6300
ccgctttcca gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg 6360
ggagaggcgg tttgcgtatt gggcgctctt ccgcttcctc gctcactgac tcgctgcgct 6420
cggtcgttcg gctgcggcga gcggtatcag ctcactcaaa ggcggtaata cggttatcca 6480
cagaatcagg ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga 6540
accgtaaaaa ggccgcgttg ctggcgtttt tccataggct ccgcccccct gacgagcatc 6600
acaaaaatcg acgctcaagt cagaggtggc gaaacccgac aggactataa agataccagg 6660
cgtttccccc tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat 6720
acctgtccgc ctttctccct tcgggaagcg tggcgctttc tcatagctca cgctgtaggt 6780
atctcagttc ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa ccccccgttc 6840
agcccgaccg ctgcgcctta tccggtaact atcgtcttga gtccaacccg gtaagacacg 6900
acttatcgcc actggcagca gccactggta acaggattag cagagcgagg tatgtaggcg 6960
gtgctacaga gttcttgaag tggtggccta actacggcta cactagaaga acagtatttg 7020
gtatctgcgc tctgctgaag ccagttacct tcggaaaaag agttggtagc tcttgatccg 7080
gcaaacaaac caccgctggt agcggtggtt tttttgtttg caagcagcag attacgcgca 7140
gaaaaaaagg atctcaagaa gatcctttga tcttttctac ggggtctgac actcagtgga 7200
acgaaaactc acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga 7260
tccttttaaa ttaaaaatga agttttaaat caatctaaag tatatatgag taaacttggt 7320
ctgacagtta ccaatgctta atcagtgagg cacctatctc agcgatctgt ctatttcgtt 7380
catccatagt tgcctgactc cccgtcgtgt agataactac gatacgggag ggcttaccat 7440
ctggccccag tgctgcaatg ataccgcgag acccacgctc accggctcca gatttatcag 7500
caataaacca gccagccgga agggccgagc gcagaagtgg tcctgcaact ttatccgcct 7560
ccatccagtc tattaattgt tgccgggaag ctagagtaag tagttcgcca gttaatagtt 7620
tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg tttggtatgg 7680
cttcattcag ctccggttcc caacgatcaa ggcgagttac atgatccccc atgttgtgca 7740
aaaaagcggt tagctccttc ggtcctccga tcgttgtcag aagtaagttg gccgcagtgt 7800
tatcactcat ggttatggca gcactgcata attctcttac tgtcatgcca tccgtaagat 7860
gcttttctgt gactggtgag tactcaacca agtcattctg agaatagtgt atgcggcgac 7920
cgagttgctc ttgcccggcg tcaatacggg ataataccgc gccacatagc agaactttaa 7980
aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc ttaccgctgt 8040
tgagatccag ttcgatgtaa cccactcgtg cacccaactg atcttcagca tcttttactt 8100
tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa aagggaataa 8160
gggcgacacg gaaatgttga atactcatac tcttcctttt tcaatattat tgaagcattt 8220
atcagggtta ttgtctcatg agcggataca tatttgaatg tatttagaaa aataaacaaa 8280
taggggttcc gcgcacattt ccccgaaaag tgccacctga cgtcgacgga tcgggagatc 8340
gatctcccga tcccctaggg tcgactctca gtacaatctg ctctgatgcc gcatagttaa 8400
gccagtatct gctccctgct tgtgtgttgg aggtcgctga gtagtgcgcg agcaaaattt 8460
aagctacaac aaggcaaggc ttgaccgaca attgcatgaa gaatctgctt agggttaggc 8520
gttttgcgct gcttcgcgat gtacgggcca gatatacgcg ttgacattga ttattgacta 8580
gttattaata gtaatcaatt acggggtcat tagttcatag cccatatatg gagttccgcg 8640
ttacataact tacggtaaat ggcccgcctg gctgaccgcc caacgacccc cgcccattga 8700
cgtcaataat gacgtatgtt cccatagtaa cgccaatagg gactttccat tgacgtcaat 8760
gggtggagta tttacggtaa actgcccact tggcagtaca tcaagtgtat c 8811
<210> 2
<211> 8961
<212> DNA
<213> Artificial sequence ()
<400> 2
atatgccaag tacgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg 60
cccagtacat gaccttatgg gactttccta cttggcagta catctacgta ttagtcatcg 120
ctattaccat ggtgatgcgg ttttggcagt acatcaatgg gcgtggatag cggtttgact 180
cacggggatt tccaagtctc caccccattg acgtcaatgg gagtttgttt tggcaccaaa 240
atcaacggga ctttccaaaa tgtcgtaaca actccgcccc attgacgcaa atgggcggta 300
ggcgtgtacg gtgggaggtc tatataagca gagctggttt agtgaaccgt cagatccgct 360
agagatccgc ggccgctaat acgactcact atagggagag ccgccaccat gaaacggaca 420
gccgacggaa gcgagttcga gtcaccaaag aagaagcgga aagtcagcag tgaaaccgga 480
ccagtggcag tggacccaac cctgaggaga cggattgagc cccatgaatt tgaagtgttc 540
tttgacccaa gggagctgag gaaggagaca tgcctgctgt acgagatcaa gtggggcaca 600
agccacaaga tctggcgcca cagctccaag aacaccacaa agcacgtgga agtgaatttc 660
atcgagaagt ttacctccga gcggcacttc tgcccctcta ccagctgttc catcacatgg 720
tttctgtctt ggagcccttg cggcgagtgt tccaaggcca tcaccgagtt cctgtctcag 780
caccctaacg tgaccctggt catctacgtg gcccggctgt atcaccacat ggaccagcag 840
aacaggcagg gcctgcgcga tctggtgaat tctggcgtga ccatccagat catgacagcc 900
ccagagtacg actattgctg gcggaacttc gtgaattatc cacctggcaa ggaggcacac 960
tggccaagat acccacccct gtggatgaag ctgtatgcac tggagctgca cgcaggaatc 1020
ctgggcctgc ctccatgtct gaatatcctg cggagaaagc agccccagct gacatttttc 1080
accattgctc tgcagtcttg tcactatcag cggctgcctc ctcatattct gtgggctaca 1140
ggcctgaagt ctggaggatc tagcggagga tcctctggca gcgagacacc aggaacaagc 1200
gagtcagcaa caccagagag cagtggcggc agcagcggcg gcagcgacaa gaagtacagc 1260
atcggcctgg ccatcggcac caactctgtg ggctgggccg tgatcaccga cgagtacaag 1320
gtgcccagca agaaattcaa ggtgctgggc aacaccgacc ggcacagcat caagaagaac 1380
ctgatcggag ccctgctgtt cgacagcggc gaaacagccg aggccacccg gctgaagaga 1440
accgccagaa gaagatacac cagacggaag aaccggatct gctatctgca agagatcttc 1500
agcaacgaga tggccaaggt ggacgacagc ttcttccaca gactggaaga gtccttcctg 1560
gtggaagagg ataagaagca cgagcggcac cccatcttcg gcaacatcgt ggacgaggtg 1620
gcctaccacg agaagtaccc caccatctac cacctgagaa agaaactggt ggacagcacc 1680
gacaaggccg acctgcggct gatctatctg gccctggccc acatgatcaa gttccggggc 1740
cacttcctga tcgagggcga cctgaacccc gacaacagcg acgtggacaa gctgttcatc 1800
cagctggtgc agacctacaa ccagctgttc gaggaaaacc ccatcaacgc cagcggcgtg 1860
gacgccaagg ccatcctgtc tgccagactg agcaagagca gacggctgga aaatctgatc 1920
gcccagctgc ccggcgagaa gaagaatggc ctgttcggaa acctgattgc cctgagcctg 1980
ggcctgaccc ccaacttcaa gagcaacttc gacctggccg aggatgccaa actgcagctg 2040
agcaaggaca cctacgacga cgacctggac aacctgctgg cccagatcgg cgaccagtac 2100
gccgacctgt ttctggccgc caagaacctg tccgacgcca tcctgctgag cgacatcctg 2160
agagtgaaca ccgagatcac caaggccccc ctgagcgcct ctatgatcaa gagatacgac 2220
gagcaccacc aggacctgac cctgctgaaa gctctcgtgc ggcagcagct gcctgagaag 2280
tacaaagaga ttttcttcga ccagagcaag aacggctacg ccggctacat tgacggcgga 2340
gccagccagg aagagttcta caagttcatc aagcccatcc tggaaaagat ggacggcacc 2400
gaggaactgc tcgtgaagct gaacagagag gacctgctgc ggaagcagcg gaccttcgac 2460
aacggcagca tcccccacca gatccacctg ggagagctgc acgccattct gcggcggcag 2520
gaagattttt acccattcct gaaggacaac cgggaaaaga tcgagaagat cctgaccttc 2580
cgcatcccct actacgtggg ccctctggcc aggggaaaca gcagattcgc ctggatgacc 2640
agaaagagcg aggaaaccat caccccctgg aacttcgagg aagtggtgga caagggcgct 2700
tccgcccaga gcttcatcga gcggatgacc aacttcgata agaacctgcc caacgagaag 2760
gtgctgccca agcacagcct gctgtacgag tacttcaccg tgtataacga gctgaccaaa 2820
gtgaaatacg tgaccgaggg aatgagaaag cccgccttcc tgagcggcga gcagaaaaag 2880
gccatcgtgg acctgctgtt caagaccaac cggaaagtga ccgtgaagca gctgaaagag 2940
gactacttca agaaaatcga gtgcttcgac tccgtggaaa tctccggcgt ggaagatcgg 3000
ttcaacgcct ccctgggcac ataccacgat ctgctgaaaa ttatcaagga caaggacttc 3060
ctggacaatg aggaaaacga ggacattctg gaagatatcg tgctgaccct gacactgttt 3120
gaggacagag agatgatcga ggaacggctg aaaacctatg cccacctgtt cgacgacaaa 3180
gtgatgaagc agctgaagcg gcggagatac accggctggg gcaggctgag ccggaagctg 3240
atcaacggca tccgggacaa gcagtccggc aagacaatcc tggatttcct gaagtccgac 3300
ggcttcgcca acagaaactt catgcagctg atccacgacg acagcctgac ctttaaagag 3360
gacatccaga aagcccaggt gtccggccag ggcgatagcc tgcacgagca cattgccaat 3420
ctggccggca gccccgccat taagaagggc atcctgcaga cagtgaaggt ggtggacgag 3480
ctcgtgaaag tgatgggccg gcacaagccc gagaacatcg tgatcgaaat ggccagagag 3540
aaccagacca cccagaaggg acagaagaac agccgcgaga gaatgaagcg gatcgaagag 3600
ggcatcaaag agctgggcag ccagatcctg aaagaacacc ccgtggaaaa cacccagctg 3660
cagaacgaga agctgtacct gtactacctg cagaatgggc gggatatgta cgtggaccag 3720
gaactggaca tcaaccggct gtccgactac gatgtggacc atatcgtgcc tcagagcttt 3780
ctgaaggacg actccatcga caacaaggtg ctgaccagaa gcgacaagaa ccggggcaag 3840
agcgacaacg tgccctccga agaggtcgtg aagaagatga agaactactg gcggcagctg 3900
ctgaacgcca agctgattac ccagagaaag ttcgacaatc tgaccaaggc cgagagaggc 3960
ggcctgagcg aactggataa ggccggcttc atcaagagac agctggtgga aacccggcag 4020
atcacaaagc acgtggcaca gatcctggac tcccggatga acactaagta cgacgagaat 4080
gacaagctga tccgggaagt gaaagtgatc accctgaagt ccaagctggt gtccgatttc 4140
cggaaggatt tccagtttta caaagtgcgc gagatcaaca actaccacca cgcccacgac 4200
gcctacctaa acgccgtcgt gggaaccgcc ctgatcaaaa agtaccctaa gctggaaagc 4260
gagttcgtgt acggcgacta caaggtgtac gacgtgcgga agatgatcgc caagagcgag 4320
caggaaatcg gcaaggctac cgccaagtac ttcttctaca gcaacatcat gaactttttc 4380
aagaccgaga ttaccctggc caacggcgag atccggaagc ggcctctgat cgagacaaac 4440
ggcgaaaccg gggagatcgt gtgggataag ggccgggatt ttgccaccgt gcggaaagtg 4500
ctgagcatgc cccaagtgaa tatcgtgaaa aagaccgagg tgcagacagg cggcttcagc 4560
aaagagtcta tcctgcccaa gaggaacagc gataagctga tcgccagaaa gaaggactgg 4620
gaccctaaga agtacggcgg cttcgacagc cccaccgtgg cctattctgt gctggtggtg 4680
gccaaagtgg aaaagggcaa gtccaagaaa ctgaagagtg tgaaagagct gctggggatc 4740
accatcatgg aaagaagcag cttcgagaag aatcccatcg actttctgga agccaagggc 4800
tacaaagaag tgaaaaagga cctgatcatc aagctgccta agtactccct gttcgagctg 4860
gaaaacggcc ggaagagaat gctggcctct gccggcgaac tgcagaaggg aaacgaactg 4920
gccctgccct ccaaatatgt gaacttcctg tacctggcca gccactatga gaagctgaag 4980
ggctcccccg aggataatga gcagaaacag ctgtttgtgg aacagcacaa gcactacctg 5040
gacgagatca tcgagcagat cagcgagttc tccaagagag tgatcctggc cgacgctaat 5100
ctggacaaag tgctgtccgc ctacaacaag caccgggata agcccatcag agagcaggcc 5160
gagaatatca tccacctgtt taccctgacc aatctgggag cccctgccgc cttcaagtac 5220
tttgacacca ccatcgaccg gaagaggtac accagcacca aagaggtgct ggacgccacc 5280
ctgatccacc agagcatcac cggcctgtac gagacacgga tcgacctgtc tcagctggga 5340
ggtgacagcg gcgggagcgg cgggagcggg gggagcacta atctgagcga catcattgag 5400
aaggagactg ggaaacagct ggtcattcag gagtccatcc tgatgctgcc tgaggaggtg 5460
gaggaagtga tcggcaacaa gccagagtct gacatcctgg tgcacaccgc ctacgacgag 5520
tccacagatg agaatgtgat gctgctgacc tctgacgccc ccgagtataa gccttgggcc 5580
ctggtcatcc aggattctaa cggcgagaat aagatcaaga tgctgagcgg aggatccgga 5640
ggatctggag gcagcaccaa cctgtctgac atcatcgaga aggagacagg caagcagctg 5700
gtcatccagg agagcatcct gatgctgccc gaagaagtcg aagaagtgat cggaaacaag 5760
cctgagagcg atatcctggt ccataccgcc tacgacgaga gtaccgacga aaatgtgatg 5820
ctgctgacat ccgacgcccc agagtataag ccctgggctc tggtcatcca ggattccaac 5880
ggagagaaca aaatcaaaat gctgtctggc ggctcaaaaa gaaccgccga cggcagcgaa 5940
ttcgagccca agaagaagag gaaagtctaa ccggtcatca tcaccatcac cattgagttt 6000
aaacccgctg atcagcctcg actgtgcctt ctagttgcca gccatctgtt gtttgcccct 6060
cccccgtgcc ttccttgacc ctggaaggtg ccactcccac tgtcctttcc taataaaatg 6120
aggaaattgc atcgcattgt ctgagtaggt gtcattctat tctggggggt ggggtggggc 6180
aggacagcaa gggggaggat tgggaagaca atagcaggca tgctggggat gcggtgggct 6240
ctatggcttc tgaggcggaa agaaccagct ggggctcgat accgtcgacc tctagctaga 6300
gcttggcgta atcatggtca tagctgtttc ctgtgtgaaa ttgttatccg ctcacaattc 6360
cacacaacat acgagccgga agcataaagt gtaaagccta ggatgcctaa tgagtgagct 6420
aactcacatt aattgcgttg cgctcactgc ccgctttcca gtcgggaaac ctgtcgtgcc 6480
agctgcatta atgaatcggc caacgcgcgg gaagaggcgg tttgcgtatt gggcgctctt 6540
ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg gctgcggcga gcggtatcag 6600
ctcactcaaa ggcggtaata cggttatcca cagaatcagg ggataacgca ggaaagaaca 6660
tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt 6720
tccataggct ccgcccccct gacgagcatc acaaaaatcg acgctcaagt cagaggtggc 6780
gaaacccgac aggactataa agataccagg cgtttccccc tggaagctcc ctcgtgcgct 6840
ctcctgttcc gaccctgccg cttaccggat acctgtccgc ctttctccct tcgggaagcg 6900
tggcgctttc tcatagctca cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca 6960
agctgggctg tgtgcacgaa ccccccgttc agcccgaccg ctgcgcctta tccggtaact 7020
atcgtcttga gtccaacccg gtaagacacg acttatcgcc actggcagca gccactggta 7080
acaggattag cagagcgagg tatgtaggcg gtgctacaga gttcttgaag tggtggccta 7140
actacggcta cactagaaga acagtatttg gtatctgcgc tctgctgaag ccagttacct 7200
tcggaaaaag agttggtagc tcttgatccg gcaaacaaac caccgctggt agcggtggtt 7260
tttttgtttg caagcagcag attacgcgca gaaaaaaagg atctcaagaa gatcctttga 7320
tcttttctac ggggtctgac actcagtgga acgaaaactc acgttaaggg attttggtca 7380
tgagattatc aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga agttttaaat 7440
caatctaaag tatatatgag taaacttggt ctgacagtta ccaatgctta atcagtgagg 7500
cacctatctc agcgatctgt ctatttcgtt catccatagt tgcctgactc cccgtcgtgt 7560
agataactac gatacgggag ggcttaccat ctggccccag tgctgcaatg ataccgcgag 7620
acccacgctc accggctcca gatttatcag caataaacca gccagccgga agggccgagc 7680
gcagaagtgg tcctgcaact ttatccgcct ccatccagtc tattaattgt tgccgggaag 7740
ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt gctacaggca 7800
tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag ctccggttcc caacgatcaa 7860
ggcgagttac atgatccccc atgttgtgca aaaaagcggt tagctccttc ggtcctccga 7920
tcgttgtcag aagtaagttg gccgcagtgt tatcactcat ggttatggca gcactgcata 7980
attctcttac tgtcatgcca tccgtaagat gcttttctgt gactggtgag tactcaacca 8040
agtcattctg agaatagtgt atgcggcgac cgagttgctc ttgcccggcg tcaatacggg 8100
ataataccgc gccacatagc agaactttaa aagtgctcat cattggaaaa cgttcttcgg 8160
ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg 8220
cacccaactg atcttcagca tcttttactt tcaccagcgt ttctgggtga gcaaaaacag 8280
gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg gaaatgttga atactcatac 8340
tcttcctttt tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca 8400
tatttgaatg tatttagaaa aataaacaaa taggggttcc gcgcacattt ccccgaaaag 8460
tgccacctga cgtcgacgga tcgggagatc gatctcccga tcccctaggg tcgactctca 8520
gtacaatctg ctctgatgcc gcatagttaa gccagtatct gctccctgct tgtgtgttgg 8580
aggtcgctga gtagtgcgcg agcaaaattt aagctacaac aaggcaaggc ttgaccgaca 8640
attgcatgaa gaatctgctt agggttaggc gttttgcgct gcttcgcgat gtacgggcca 8700
gatatacgcg ttgacattga ttattgacta gttattaata gtaatcaatt acggggtcat 8760
tagttcatag cccatatatg gagttccgcg ttacataact tacggtaaat ggcccgcctg 8820
gctgaccgcc caacgacccc cgcccattga cgtcaataat gacgtatgtt cccatagtaa 8880
cgccaatagg gactttccat tgacgtcaat gggtggagta tttacggtaa actgcccact 8940
tggcagtaca tcaagtgtat c 8961

Claims (4)

1. A method of gene knockout comprising:
according to the translation initiation region sequence characteristics of the gene to be knocked out, a 20bp-NGG target sequence is designed to contain a complete initiation codon ATG;
positioning ABE to a target sequence by utilizing a sgRNA sequence to mutate a target single base A in an initiation codon into G, so that the initiation codon loses functions, and a target gene is knocked out;
wherein the target single base A is located at positions 4-7 of the target sequence; the sgRNA sequence is a 20bp sequence which is complementary and corresponds to a target sequence,
wherein ABE is selected from pCMV-ABEmax SEQ ID NO. 1;
wherein the method is used for knocking out a target gene HDAC1, and the sgRNA sequence corresponding to the method is complementary with the following target gene sequences:
Sg-1:AGCAAGATGGCGCAGACGCAGGG。
2. use of the method of claim 1 for performing an HDAC1 gene knockout of the cell line HEK 293T.
3. Isolated cell lines or their subcultures obtained according to the use of claim 2.
4. A kit for HDAC1 gene knock-out comprising the sgRNA, ABE, and amplification reagents of claim 1.
CN201910105331.4A 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application Active CN109706185B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910105331.4A CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910105331.4A CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Publications (2)

Publication Number Publication Date
CN109706185A CN109706185A (en) 2019-05-03
CN109706185B true CN109706185B (en) 2021-07-27

Family

ID=66264246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910105331.4A Active CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Country Status (1)

Country Link
CN (1) CN109706185B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029096B (en) * 2019-05-09 2023-05-12 上海科技大学 Adenine base editing tool and application thereof
CN110407945A (en) * 2019-06-14 2019-11-05 上海科技大学 A kind of adenine base edit tool and application thereof
CN117587064A (en) * 2021-10-29 2024-02-23 中国种子集团有限公司 Method for improving amylose content of rice by mutating OsWaxy gene by single base gene editing technology
CN114561429A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Treatment method for inhibiting HBV surface antigen based on base editing ATG initiation codon
CN114561392A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Method for removing HBV e antigen by closing target gene based on base editing technology
CN115820728A (en) * 2022-07-11 2023-03-21 上海贝斯昂科生物科技有限公司 Gene editing method and application
CN117126818B (en) * 2023-10-25 2024-02-02 江西农业大学 Method for constructing gE gene deletion PRV strain by utilizing ABE and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL258821B (en) * 2015-10-23 2022-07-01 Harvard College Nucleobase editors and uses thereof
US11542509B2 (en) * 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN107164377A (en) * 2017-06-12 2017-09-15 王小平 Gene knockout method and its application based on base editor
CN108753823B (en) * 2018-06-20 2022-09-23 李广磊 Method for realizing gene knockout by using base editing technology and application thereof

Also Published As

Publication number Publication date
CN109706185A (en) 2019-05-03

Similar Documents

Publication Publication Date Title
CN109706185B (en) Method for realizing gene knockout based on base editing system mutation initiation codon and application
CN107557388B (en) Lentiviral vector for CAR-T preparation and construction method and application thereof
CN101240277B (en) PCR detection method of transgene paddy strain Bt Shanyou 63
CN108271384A (en) The molecular complex that the method for converting of the genome sequence of the gram-positive bacteria of the nucleic acid base of DNA sequence dna is targeted for special sex reversal and its is used
CN113403294B (en) Fusion protein, base editing tool and application thereof
CN108410787A (en) A kind of recombined bacillus subtilis of synthesis new tetroses of lactoyl-N- and its construction method and application
CN112048484A (en) Gene VII-type Newcastle disease recombinant virus for expressing infectious bursal disease virulent strain VP2 protein and vaccine
CN110938651A (en) Targeting vector, method for constructing BAC clone by targeting and integrating exogenous gene to mouse F4/80 exon 22 site and application
CN113943720A (en) Apolygus lucorum GRK gene, dsRNA thereof, synthetic method and application thereof
CN111500641A (en) Preparation method of pig with human nerve growth factor gene
US20010010928A1 (en) Protozoan expression system
KR102009273B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type O-TAW97
CN114736308B (en) Preparation and application of coccidian antigen peptide/IL 5 fusion protein gene engineering bacteria
CN107287201B (en) Strong broad-spectrum promoter and application thereof
KR101535070B1 (en) Recomnication expression vector of vascular growth factor and the vascular growth factor expressing stem cell line thereof
KR100721140B1 (en) Shuttle vectors for Leuconostoc and E. coli
CN110129366B (en) Carrier combination and application thereof
KR101891602B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type O, SEA and ME-SA topotype
KR20170017115A (en) Method of testing genotype and phenotype for simultaneously predicting drug resistance against protease inhibitor, reverse transcriptase inhibitor and integrase inhibitor
CN109852589A (en) A kind of clone of cymbidium mosaic virus strain and its transcription vector building
CN112852651B (en) Method for increasing yield of hydrocortisone produced by saccharomyces cerevisiae biotransformation
CN114181939B (en) Recombinant coccidium vector expressing NA4 protein and fluorescent tag and detection method thereof
CN108588100B (en) Inhibin B double-gene fragment combined expression vector and application thereof
CN114231566B (en) R26-e (CN 362-1) carrier and preparation method thereof
KR102009265B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type SAT1 BOT

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 100081 Beijing city Haidian District Dahui Temple Road, No. 12

Applicant after: Institute of Science and Technology, National Health Commission

Address before: 100081 Beijing city Haidian District Dahui Temple Road, No. 12

Applicant before: RESEARCH INSTITUTE OF PRC NATIONAL HEALTH AND FAMILY PLANNING COMMISSION

GR01 Patent grant
GR01 Patent grant